Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DC.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DC.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CP.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CP.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EQ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EQ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JU.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JU.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JU.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CJ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CJ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CJ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DE.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DE.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DE.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.19ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.19ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used